End-to-End Revenue Management for Pharmaceutical Companies
Manage the full complexity of pharma revenue — from contract pricing and 340B compliance to chargeback automation and gross-to-net transparency — in a single, auditable platform.
Manufacturer Chargeback Dashboard
Process manufacturer chargebacks with automated validation and matching
Claims by Status
Claims by Category
Monthly Processing Volume
Recent Chargeback Claims
8 records| Claim ID↑ | Manufacturer↕ | Category↕ | Amount↕ | Submitted↕ | Match Rate↕ | Status↕ |
|---|---|---|---|---|---|---|
| MC-7801 | Pfizer Inc. | Contract Price | $234,500 | 2025-06-18 | 98.2% | Validated |
| MC-7802 | Johnson & Johnson | Rebate Credit | $178,320 | 2025-06-17 | 96.7% | Pending |
| MC-7803 | AbbVie Corp. | Promotional | $89,150 | 2025-06-16 | 94.1% | Validated |
| MC-7804 | Merck & Co. | Contract Price | $312,800 | 2025-06-15 | 99.1% | Settled |
| MC-7805 | Bristol-Myers Squibb | Administrative | $45,670 | 2025-06-14 | 87.3% | Disputed |
| MC-7806 | Eli Lilly | Rebate Credit | $156,900 | 2025-06-13 | 97.5% | Validated |
| MC-7807 | Novartis AG | Contract Price | $267,400 | 2025-06-12 | 95.8% | Pending |
| MC-7808 | Roche Holdings | Promotional | $72,300 | 2025-06-11 | 68.4% | Rejected |
Distributor Chargeback
Pharma Revenue Is Uniquely Complex
Pharmaceutical companies face a web of regulatory mandates, multi-channel pricing, and post-invoice adjustments that legacy systems were never designed to handle. The result: margin leakage, audit exposure, and months of manual reconciliation.
Chargeback Chaos
Wholesalers, GPOs, and PBMs submit thousands of chargeback claims monthly. Manual validation leads to overpayments, disputes, and write-offs that erode margins.
Gross-to-Net Opacity
With Medicaid, 340B, commercial rebates, and distribution fees, the gap between gross and net revenue grows wider — and harder to forecast accurately.
Contract Compliance Risk
Managing hundreds of contracts across government programs, GPOs, and commercial payers with different terms, tiers, and eligibility rules creates constant compliance exposure.
Pricing Governance Gaps
WAC, ASP, AMP, and Best Price calculations require precise, auditable data flows. Manual processes introduce errors that can trigger regulatory penalties.
One Platform for Every Dollar Between Gross and Net
IMA360 connects your contracts, chargebacks, rebates, and pricing into a single system — giving finance, commercial, and compliance teams a shared, auditable view of every revenue adjustment.
Built for Pharma Complexity
Unlike generic pricing tools that treat pharma as an afterthought, IMA360 was built from the ground up to handle the full spectrum of pharmaceutical revenue management — from government pricing to commercial chargebacks.
Request a DemoFull EDI Chargeback Automation
Native support for EDI 845, 844, and 849 transactions — from claim receipt through validation and settlement. No middleware required.
Gross-to-Net Transparency
Real-time visibility into every deduction between WAC and pocket price — Medicaid, 340B, commercial rebates, distribution fees, and chargebacks.
GPO and 340B Compliance
Automated eligibility verification, roster management, and contract compliance across government and commercial programs.
ERP-Agnostic Architecture
Works alongside SAP, Oracle, or any ERP without vendor lock-in. Pre-configured connectors reduce implementation time by 60%.
Auditable to the Transaction
Every pricing decision, rebate calculation, and chargeback settlement is traced with a complete audit trail for regulatory review.
See How IMA360 Transforms Pharma Revenue Management
Request a demo tailored to your organization's specific challenges — chargebacks, rebates, gross-to-net, or all of the above.
Frequently asked questions
How does IMA360 handle 340B chargeback validation?
IMA360 automatically validates 340B chargeback claims against contract terms, GPO roster data, and eligibility rules. The system flags discrepancies in real time and provides a complete audit trail for every claim processed.
Can IMA360 integrate with our existing ERP and EDI systems?
Yes. IMA360 is fully ERP-agnostic and supports native EDI 845/844/849 processing. Pre-built connectors for SAP, Oracle, and other major ERPs enable integration in weeks, not months.
How does the platform improve gross-to-net forecasting?
IMA360 centralizes all post-invoice adjustments — rebates, chargebacks, fees, and returns — into a single view. Real-time accrual tracking and historical trend analysis enable more accurate GTN forecasts with continuous variance monitoring.
What compliance reporting does IMA360 support?
The platform provides audit-ready reporting for Medicaid, 340B, Best Price, ASP, and AMP calculations. Every data point is traceable to its source transaction, supporting both internal audits and regulatory submissions.
How long does implementation typically take?
Most pharmaceutical implementations go live within 12 to 16 weeks. IMA360's pre-configured industry templates and guided onboarding accelerate deployment by up to 60% compared to traditional implementations.